Conference: 28 – 29 October 2020

Workshops: 30 October 2020

Location: Virtual Conference: Online Access Only

Website: http://www.microbiologyeastcoast.com/farmavitaWB

Exploring the current approaches towards improved contamination control

The pharmaceutical microbiology industry has seen many changes during the progression into the 21st century. With advances in rapid microbiological methods, revisions being made to regulations in the industry, enhanced knowledge of the human microbiome, and novel testing methods, this industry is ever expanding.

Join industry experts to discuss and analyze the latest advances and challenges within the industry. Network with industry professionals, discuss the revision of Annex 1, explore data integrity considerations for conventional and rapid microbiology methods, analyze arising issues with environmental monitoring and gain insight into an industry perspective on automated endotoxin testing and process automation.

Pharmaceutical Microbiology East Coast will discuss the ongoing complication of personnel derived contaminations from the FDA. Gain valuable insight towards microbiological quality considerations in non-sterile manufacturing and control of BCC from Parexel. Learn from the perspective of the US Pharmacopeia on container closure integrity evaluation and explore the work at Genentech covering technical considerations for microbial QC of raw materials used in biotechnology and the past, current and future state of Mycoplasma testing.


HIGHLIGHTS FOR 2020:

  • Discuss ongoing complication of personnel derived contaminations from the FDA
  • Gain valuable insight towards microbiological quality considerations in non-sterile manufacturing and control of BCC from Parexel
  • Learn from the perspective of the US Pharmacopeia on container closure integrity evaluation
  • Examine an end-to-end contamination risk assessment for autologous cell therapy from Juno Therapeutics
  • Explore a back to back Genentech session covering technical considerations for microbial QC of raw materials used in biotechnology and the past, current and future state of Mycoplasma testing

 

WHO SHOULD ATTEND?

• Senior Microbiologist
• Lead Scientist
• Laboratory Manager
• QA Specialist
• Drug Substance External Manufacturer
• QC Scientists
• Heads of Quality
• Business Development Manager
• Pharmaceutical Microbiology Consultant
• Higher Pharmacopoeial Scientist
• Analytical Standards Specialist

 

For details and to register, visit the website at http://www.microbiologyeastcoast.com/farmavitaWB